Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.
about
From hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspectiveTranslating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validationmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentmiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimirBiomarkers in DILI: One More Step ForwardMicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling PathwayMechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.Circulating Plasma and Exosomal microRNAs as Indicators of Drug-Induced Organ Injury in Rodent ModelsCirculating RNA molecules as biomarkers in liver disease.Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.High Throughput qPCR Expression Profiling of Circulating MicroRNAs Reveals Minimal Sex- and Sample Timing-Related Variation in Plasma of Healthy Volunteers.Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients.Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.Translational biomarkers of acetaminophen-induced acute liver injuryPotential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis.miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage.Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in RatsClinical characteristics of drug-induced liver injury and related risk factors.Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.Circulating microRNAs Correlated with Bone Loss Induced by 45 Days of Bed Rest.The role for microRNAs in drug toxicity and in safety assessment.Circulating RNA: looking at the liver through a frosted glass.Role of Stem Cells Transplantation in Tissue Regeneration After Acute or Chronic Acetaminophen Induced Liver Injury.The transformation in biomarker detection and management of drug-induced liver injuryMicroRNA Biomarkers of Toxicity in Biological Matrices.The past and present of serum aminotransferases and the future of liver injury biomarkers.Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.MicroRNAs in injury and repair.Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test Sites.Absent MicroRNAs in Different Tissues of Patients with Acquired CardiomyopathyMicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury.MicroRNA-125b-5p mimic inhibits acute liver failure.The effects of storage temperature and duration of blood samples on DNA and RNA qualities.
P2860
Q26738626-F12EEFE5-34FC-41F9-9A80-4A5CAB84E3A7Q26778915-8EEE1E27-A8EE-4ECA-B573-F47E8771FE8CQ26778918-C082FBE9-3154-4B34-AE20-C94779D3C776Q26991956-628BD60B-22A2-4D7A-8DF1-C380A7391F2DQ28071799-291B95CC-BFB6-4FA9-9569-FEA5DC518564Q28551191-3FB84BE0-9CA1-46C9-85F4-628C82E57365Q33848167-0330B8E0-7793-4A1C-AD13-09BE88A4BF89Q33878277-832A66FC-947C-481D-A0A1-1976D83567ECQ34486635-DE16DBF6-3AF8-43A1-A16B-F0814C89062DQ35379600-16C1762D-0512-4501-B1ED-A9648AAB04C0Q35750622-93C674CB-389D-4ECC-A4B4-F531CFD98CA8Q35796897-C7A130DB-5814-4BC8-917F-C54853C7FC44Q35877139-3977E5DA-0E49-4A34-9199-08585F4935BBQ35903687-57536872-C14C-4192-B981-1CFB705A63DCQ35973626-4D5BDDE7-75F1-4734-B4B5-4A6A75EF9565Q36001451-FF82F1AF-29EB-41CF-B404-D1E312DA63F4Q36022680-1B3DF8E6-2FED-4FAF-9943-035C3DE1A632Q36187981-4D04D7DF-463B-40B5-B52D-342BC224B2C5Q36381558-50CCD5E8-72CF-4902-B0F9-1C8654517199Q36618929-D3D3C984-4AB6-4A4F-BB72-B1344609254CQ36879545-203AE63D-744B-4E7F-9AB3-453E65DBE411Q37195557-7AD24CAE-54E3-4C31-98F2-C30B236C6400Q37228567-9AC93DB4-9211-4572-8BC0-6BEBEDA5B255Q37289416-0919CFAC-7093-4E49-BA4F-F72D73BC8E98Q37417538-D12A1E4E-E7F9-4ECE-9029-22EE064D87E5Q37639778-E05BB853-51BC-4F96-BFFB-3B90592DC989Q38367620-E6DAF91F-4607-4CAF-8F62-170AADD17499Q38652065-8A527C18-EE4A-4E8F-91C7-BB7D7F1247A6Q38664055-0C05894C-5535-4DE6-919B-699807B6FC1EQ38848580-FB9F9947-C611-4DEE-AA8F-C65897882BABQ38909827-BEAA14E0-5841-489B-B0D6-9341C17EDB7CQ38926316-6F2E4AC7-8CB2-4F09-AB92-854E5B02939BQ39059921-2D8B556E-9793-41E5-AC0E-7B899776B844Q39304689-5CCB7738-6F03-451E-AD17-5126CBBA3AC8Q39387022-97513101-23E8-40F2-B86F-84555E0BB5BAQ39412220-0CD64569-A3A8-4FE4-BDB8-DC5C2642884AQ39542328-499F82E7-A363-4C85-9FF8-283C7A265A6AQ40309782-FC1A031F-F725-4B8D-B55B-71C571E2FE04Q40639545-B9E2C7E9-BA6A-401E-AA91-B422BC3C6358Q41677430-77161119-B224-47A1-A413-8856F10491BF
P2860
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@ast
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@en
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@nl
type
label
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@ast
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@en
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@nl
prefLabel
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@ast
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@en
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@nl
P2093
P2860
P921
P356
P1476
Circulating microRNA profiles ...... oxicity or ischemic hepatitis.
@en
P2093
Chitra Kanchagar
Hartmut Jaeschke
Jeanine Ward
Rosalind C Lee
Steven C Curry
Victor R Ambros
P2860
P304
12169-12174
P356
10.1073/PNAS.1412608111
P407
P577
2014-08-04T00:00:00Z